• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢型谷氨酸受体 5 敲除可挽救亨廷顿病小鼠模型的肥胖表型。

Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's disease.

机构信息

Departamento de Farmacologia, ICB, Universidade Federal de Minas Gerais, Ave. Antonio Carlos 6627, Belo Horizonte, MG, CEP 31270-901, Brazil.

Departamento de Bioquímica e Imunologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, CEP 31270-901, Brazil.

出版信息

Sci Rep. 2022 Apr 4;12(1):5621. doi: 10.1038/s41598-022-08924-4.

DOI:10.1038/s41598-022-08924-4
PMID:35379852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8980063/
Abstract

Obesity represents a global health problem and is characterized by metabolic dysfunctions and a low-grade chronic inflammatory state, which can increase the risk of comorbidities, such as atherosclerosis, diabetes and insulin resistance. Here we tested the hypothesis that the genetic deletion of metabotropic glutamate receptor 5 (mGluR5) may rescue metabolic and inflammatory features present in BACHD mice, a mouse model of Huntington's disease (HD) with an obese phenotype. For that, we crossed BACHD and mGluR5 knockout mice (mGluR5) in order to obtain the following groups: Wild type (WT), mGluR5, BACHD and BACHD/mGluR5 (double mutant mice). Our results showed that the double mutant mice present decreased body weight as compared to BACHD mice in all tested ages and reduced visceral adiposity as compared to BACHD at 6 months of age. Additionally, 12-month-old double mutant mice present increased adipose tissue levels of adiponectin, decreased leptin levels, and increased IL-10/TNF ratio as compared to BACHD mice. Taken together, our preliminary data propose that the absence of mGluR5 reduce weight gain and visceral adiposity in BACHD mice, along with a decrease in the inflammatory state in the visceral adipose tissue (VAT), which may indicate that mGluR5 may play a role in adiposity modulation.

摘要

肥胖代表着一个全球性的健康问题,其特征是代谢功能紊乱和低度慢性炎症状态,这会增加合并症的风险,如动脉粥样硬化、糖尿病和胰岛素抵抗。在这里,我们检验了这样一个假设,即代谢型谷氨酸受体 5 (mGluR5) 的基因缺失可能会改善 BACHD 小鼠(一种具有肥胖表型的亨廷顿病的小鼠模型)存在的代谢和炎症特征。为此,我们将 BACHD 小鼠与 mGluR5 基因敲除(mGluR5)小鼠进行杂交,以获得以下组别:野生型(WT)、mGluR5、BACHD 和 BACHD/mGluR5(双突变小鼠)。我们的结果表明,与 BACHD 小鼠相比,在所有测试的年龄段,双突变小鼠的体重都有所下降,而在 6 个月大时,内脏脂肪也有所减少。此外,与 BACHD 小鼠相比,12 个月大的双突变小鼠的脂肪组织中脂联素水平增加,瘦素水平降低,IL-10/TNF 比值升高。综上所述,我们的初步数据表明,mGluR5 的缺失可减少 BACHD 小鼠的体重增加和内脏脂肪堆积,并降低内脏脂肪组织(VAT)的炎症状态,这表明 mGluR5 可能在肥胖调节中发挥作用。

相似文献

1
Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's disease.代谢型谷氨酸受体 5 敲除可挽救亨廷顿病小鼠模型的肥胖表型。
Sci Rep. 2022 Apr 4;12(1):5621. doi: 10.1038/s41598-022-08924-4.
2
Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation.代谢型谷氨酸受体 5 缺失加速与年龄相关的神经退行性变和神经炎症。
Neurochem Int. 2019 Jun;126:218-228. doi: 10.1016/j.neuint.2019.03.020. Epub 2019 Mar 29.
3
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.代谢型谷氨酸受体 5 正变构调节剂在亨廷顿病的小鼠模型中具有神经保护作用。
Br J Pharmacol. 2013 Jun;169(4):909-21. doi: 10.1111/bph.12164.
4
mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.mGluR5 通过 N-钙黏蛋白/β-连环蛋白复合物调节亨廷顿病中的 REST/NRSF 信号。
Mol Brain. 2020 Aug 28;13(1):118. doi: 10.1186/s13041-020-00657-7.
5
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotype.mGluR5 缺失导致与年龄相关的突触可塑性损伤,并且不能改善亨廷顿病表型。
Sci Rep. 2022 May 28;12(1):8982. doi: 10.1038/s41598-022-13029-z.
6
Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.代谢型谷氨酸受体5基因敲除促进亨廷顿舞蹈病小鼠模型中的运动和生化改变。
Hum Mol Genet. 2014 Apr 15;23(8):2030-42. doi: 10.1093/hmg/ddt598. Epub 2013 Nov 26.
7
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.mGluR5 正变构调节剂 VU0409551 改善亨廷顿病小鼠模型的突触可塑性和记忆。
J Neurochem. 2018 Oct;147(2):222-239. doi: 10.1111/jnc.14555. Epub 2018 Sep 11.
8
Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.Sim1 神经元中突变 huntingtin 缺失对 BACHD 亨廷顿病小鼠模型代谢和行为的影响。
Sci Rep. 2016 Jun 23;6:28322. doi: 10.1038/srep28322.
9
Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease.在亨廷顿病BACHD小鼠模型中,类固醇生成因子1神经元中突变亨廷顿蛋白缺失对精神和代谢表型的影响。
PLoS One. 2014 Oct 1;9(10):e107691. doi: 10.1371/journal.pone.0107691. eCollection 2014.
10
The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.mGluR5 正变构调节剂 CDPPB 改善亨廷顿病小鼠模型的病理和表型特征。
Neurobiol Dis. 2015 Jan;73:163-73. doi: 10.1016/j.nbd.2014.08.021. Epub 2014 Aug 24.

引用本文的文献

1
Concomitant pathologies and their impact on Huntington's disease. A brief review of current evidence.伴随病变及其对亨廷顿舞蹈症的影响。当前证据简述。
J Neural Transm (Vienna). 2025 Jun 21. doi: 10.1007/s00702-025-02957-5.
2
Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy activation of the AMPK signaling pathway.代谢型谷氨酸受体5的抑制通过增强AMPK信号通路的自噬激活来减轻肝脂肪变性。
World J Gastroenterol. 2025 Feb 21;31(7):98852. doi: 10.3748/wjg.v31.i7.98852.
3
Associations between GRM7 polymorphisms and obesity in patients selected for sleeve gastrectomy.

本文引用的文献

1
Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior.代谢型谷氨酸受体5的负性调节作为肥胖和暴饮暴食样行为的潜在治疗策略
Front Neurosci. 2021 Feb 10;15:631311. doi: 10.3389/fnins.2021.631311. eCollection 2021.
2
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an <em>in vitro</em> model of benign steatosis.代谢型谷氨酸受体 5 的选择性阻断可减轻良性脂肪变性的体外模型中的脂肪堆积。
Eur J Histochem. 2020 Nov 10;64(4):3175. doi: 10.4081/ejh.2020.3175.
3
Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia.
GRM7 多态性与袖状胃切除术患者肥胖的相关性。
Metab Brain Dis. 2023 Dec;38(8):2765-2771. doi: 10.1007/s11011-023-01313-4. Epub 2023 Oct 26.
4
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotype.mGluR5 缺失导致与年龄相关的突触可塑性损伤,并且不能改善亨廷顿病表型。
Sci Rep. 2022 May 28;12(1):8982. doi: 10.1038/s41598-022-13029-z.
微生物组分析揭示了精神分裂症代谢型谷氨酸受体5基因敲除小鼠模型中的肠道菌群失调。
Front Cell Dev Biol. 2020 Oct 29;8:582320. doi: 10.3389/fcell.2020.582320. eCollection 2020.
4
mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.mGluR5 通过 N-钙黏蛋白/β-连环蛋白复合物调节亨廷顿病中的 REST/NRSF 信号。
Mol Brain. 2020 Aug 28;13(1):118. doi: 10.1186/s13041-020-00657-7.
5
Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease.亨廷顿病 BACHD 鼠模型外周器官的炎症变化。
Life Sci. 2019 Sep 1;232:116653. doi: 10.1016/j.lfs.2019.116653. Epub 2019 Jul 11.
6
Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation.代谢型谷氨酸受体 5 缺失加速与年龄相关的神经退行性变和神经炎症。
Neurochem Int. 2019 Jun;126:218-228. doi: 10.1016/j.neuint.2019.03.020. Epub 2019 Mar 29.
7
Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5.触屏测试揭示了一种缺乏代谢型谷氨酸受体 5 的精神分裂症小鼠模型中的临床相关认知异常。
Sci Rep. 2018 Nov 6;8(1):16412. doi: 10.1038/s41598-018-33929-3.
8
mGluR5 mediates post-radiotherapy fatigue development in cancer patients.代谢型谷氨酸受体 5 介导癌症患者放疗后疲劳的发生。
Transl Psychiatry. 2018 May 30;8(1):110. doi: 10.1038/s41398-018-0161-3.
9
Body weight is a robust predictor of clinical progression in Huntington disease.体重是亨廷顿病临床进展的有力预测指标。
Ann Neurol. 2017 Sep;82(3):479-483. doi: 10.1002/ana.25007. Epub 2017 Aug 22.
10
The impact of obesity on neurodegenerative diseases.肥胖对神经退行性疾病的影响。
Life Sci. 2017 Aug 1;182:22-28. doi: 10.1016/j.lfs.2017.06.002. Epub 2017 Jun 3.